Redmile Group
Healthcare-focused hedge fund and crossover investor backing biotech, therapeutics, and life sciences companies from early stage to public markets.
San Francisco, United States · 62+ investments · 47 portfolio companies
- Headquarters
- San Francisco, United States
- Founded
- 2007
- Website
- redmilegroup.com
- AUM
- $1.4B
- Portfolio Companies
- 47
- Total Investments
- 62
- Last Investment
- Aug 2026
- Geographic Focus
- United States
Indexed holds 47 portfolio companies and 62 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Redmile Group is a Venture Capital firm based in San Francisco, United States. It has made 62 investments, including Neuron23, Genalyte and Abcuro. Focus areas include Biotech and Healthcare.
Portfolio47
Co-investors24
Sign up to view co-investors
24 co-investors across 109 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×12 · Other ×4 · Corporate VC ×3 · 88 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/redmile-group"><img src="https://indexed.vc/api/badge/investor/redmile-group" alt="Redmile Group on Indexed.vc" width="260" height="76" /></a>